Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes-Reference-Cited by-同舟云学术

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes

Published:2017-07-27 Issue:11 Volume:19 Page:1546-1554
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Owens David R.¹^ORCID,Bolli Geremia B.²,Charbonnel Bernard³,Haak Thomas⁴,Landgraf Wolfgang⁵,Porcellati Francesca²,Traylor Louise⁶,Kautzky-Willer Alexandra⁷^ORCID

Affiliation:

1. Diabetes Research Group, Institute of Life Sciences, College of Medicine; Swansea University; Swansea UK

2. Department of Medicine; University of Perugia School of Medicine; Perugia Italy

3. University of Nantes; Nantes France

4. Diabetes Center Mergentheim; Bad Mergentheim Germany

5. Sanofi; Frankfurt Germany

6. Sanofi US, Inc.; Bridgewater New Jersey

7. Department of Endocrinology and Diabetes, Gender Medicine; Medical University of Vienna; Vienna Austria

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12966/fullpdf

Reference33 articles.

1. World Health Organization Global report on diabetes: executive summary 2016 http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf

2. Standards of medical care in diabetes-2017;American Diabetes Association;Diabetes Care,2017

3. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

4. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

5. Effect of gender on treatment outcomes in type 2 diabetes mellitus;McGill;Diabetes Res Clin Pract,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in type 2 diabetes: an opportunity for personalized medicine;Biology of Sex Differences;2023-12-13

2. Diagnostik und Therapie des Typ-2-Diabetes: Auch das Geschlecht berücksichtigen;Info Diabetologie;2023-04-26

3. Feminism, gender medicine and beyond: a feminist analysis of "gender medicine";International Journal for Equity in Health;2021-08-03

4. Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial;Diabetes, Obesity and Metabolism;2020-05-29

5. Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL;Diabetes, Obesity and Metabolism;2019-11-07